Recombinant Vaccines Market to Exhibit a CAGR of 11.3% by 2027; Surging Cases of Hepatitis B to Accelerate Market Possibilities, states Fortune Business Insights™

The global “recombinant vaccines market” size is expected to reach USD 25.32 billion by 2027, exhibiting a CAGR of 11.3% between 2019 to 2027. The introduction of innovative recombinant vaccines owing to the incidence of several infectious viruses such as coronavirus and hepatitis B will uplift the market potential during the forecast period, states Fortune Business Insights, in a report, titled “Recombinant Vaccines Market Size, Share & COVID-19 Impact Analysis, By Type (Subunit and Live Attenuated), By Route of Administration (Parenteral and Oral), By Disease Indication (Human Papillomavirus (HPV), Hepatitis B, Rotavirus, Herpes Zoster, Meningococcal B, and Others), By Distribution Channel (Hospital & Retail Pharmacies, Government Suppliers and Others) and Geography Forecast, 2020-2027.” The market size stood at USD 10.82 billion in 2019.

The coronavirus emergency has given immense loss to industries and sectors across the globe. The governments of several countries have instigated lockdown to thwart the spread of this deadly virus. Such plans have caused disturbances in the production and supply chain. But, with time and resolution, we will be able to combat this stern time and get back to normality. Our well-revised reports will help companies to receive in-depth information about the present scenario of every market so that you can adopt the necessary strategies accordingly.

To get to know more about the short-term and long-term impacts of COVID-19 on this market, please visit:

https://www.fortunebusinessinsights.com/industry-reports/recombinan...

Heavy Demand for Vaccines to Escalate Business During Coronavirus

The growing demand for immunization drugs and vaccines due to the extensive spread of the disease amid coronavirus will improve the prospects of the market. The enormous R&D spending by industry players to develop recombinant COVID-19 vaccine will enable speedy expansion of the market in the forthcoming years. For instance, Novavax, a pipeline candidate NVX-CoV2373 is in the phase-1 clinical study against COVID-19. The ongoing clinal trials by pharmaceutical giants for the introduction of an effective COVID vaccine will accelerate the market revenue in the foreseeable future.

Related Report

POC CT Imaging Systems Market

Computed Tomography Scanners Market

Hunter Syndrome Treatment Market

Medical Carts Market

Hydroxychloroquine Market

Medical Electrodes Market

Biomaterials Market

Immune Health Supplements Market

Medical Swabs Market

Oncology Drugs Market

Artificial Tears Market

Drug Delivery Systems Market

Heparin Market

Women's Health Market

Medical X-ray Market

About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Us:

Fortune Business Insights™ Pvt. Ltd.

308, Supreme Headquarters,

Survey No. 36, Baner,

Pune-Bangalore Highway,

Pune - 411045, Maharashtra, India.

Phone:

US :+1 424 253 0390

UK : +44 2071 939123

APAC : +91 744 740 1245

Email:sales@fortunebusinessinsights.com

LinkedIn | Twitter | Blogs

Views: 7

Comment

You need to be a member of Recampus to add comments!

Join Recampus

© 2021   Created by Aprendiendo Real Estate.   Powered by

Badges  |  Report an Issue  |  Terms of Service